About Snaprx India Private Limited
Data last updated:
Snaprx India Private Limited is a private limited company based in Nagpur, Maharashtra, India, a subsidiary of L.Focus Consultancy Inc.. It operates in the healthtech and medical tech solutions segment of the healthcare sector. It was incorporated on 30 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016PTC283128. Its GSTIN is 27AAXCS2871B1Z0 (Maharashtra).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹34.11 Lakh. It is led by directors including Kamal Abhimanyu Kukreja and Vijay Cheturam Kukreja.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 38 Pannalal Deshraj Layout Bank Colony Near Samadha Ashram Jaripatka, Nagpur, Maharashtra, India – 440014.
As per the financials filed for FY 2024, the company reported a revenue of ₹1 Lakh, a growth of 43% compared to the previous year. For the same year it recorded a net loss of ₹75,279 (net margin -75%) and EBITDA of -₹70,882 (EBITDA margin -70.6%). Revenue has declined at a compounded annual rate (CAGR) of 70% over three years and 44% over five years.
The company is associated with 1 brand: SnapRx.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website snaprx.in.
Company details
Contact details
Snaprx India Private Limited's registered office is in Nagpur, Maharashtra. Its website is snaprx.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address38 Pannalal Deshraj Layout Bank Colony Near Samadha Ashram Jaripatka, Nagpur, Maharashtra, India – 440014
- IndustryHealthcare, HealthTech & Medical Tech Solutions, Telemedicine & Virtual Healthcare
To see the full contact details of Snaprx India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Snaprx India is information and communication. In detail, this covers publishing of computer operating systems, system software, application software, games, etc..
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| J | Information and communication | J2 | Publishing of computer operating systems, system software, application software, games, etc. |
To see the full business activity and turnover split of Snaprx India Private Limited, buy the company report.
Financials of Snaprx India Private Limited
FY 2024 filings availableSnaprx India Private Limited reported revenue of ₹1 Lakh (up 43% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 43% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 44%. EBITDA fell 64% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹70,882 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹75,279 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -70.6% | ||||
| Net Profit Margin | -75% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Snaprx India Private Limited, buy the company report.
Board of directors of Snaprx India Private Limited
Snaprx India has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamal Abhimanyu Kukreja Also directs: Purethanol Industries Private Limited, Household Pharmaceuticals Limited, Innovate Organics Private Limited and 3 more | Director | 30 Jun 2016 | 10 Years 4 Months | Current |
| Vijay Cheturam Kukreja | Director | 30 Jun 2016 | 10 Years 4 Months | Current |
| Dinesh Cheturam Kukreja Also directs: Purethanol Industries Private Limited, Innovate Organics Private Limited, Taap Choice Foods Private Limited and 3 more | Director | 30 Jun 2016 | 10 Years 4 Months | Current |
Auditor
Snaprx India Private Limited is audited by K P SHAHASRUBUDDE & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K P SHAHASRUBUDDE & CO | FY 2023 | 117298W |
Shareholding
The shareholding of Snaprx India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Snaprx India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Snaprx India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Snaprx India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Snaprx India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAXCS2871B1Z0 | Maharashtra | Active | 04 Jul 2019 |
To see the full GST registrations and return filing status of Snaprx India Private Limited, buy the company report.
Recent activity
Snaprx India Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Vijay Kumar Jadwani ceased to be Director on 09 Sep 2018.
Frequently asked questions
Snaprx India is an active private limited company based in Nagpur, Maharashtra, India. The company works in healthtech and medical tech solutions, within the healthcare industry. It was incorporated on 30 June 2016 (10+ years old) and is registered under CIN U74999MH2016PTC283128.
Snaprx India has 3 current directors:
- Kamal Abhimanyu Kukreja - Director
- Vijay Cheturam Kukreja - Director
- Dinesh Cheturam Kukreja - Director
The latest financial statements of Snaprx India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Snaprx India is 27AAXCS2871B1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Snaprx India is U74999MH2016PTC283128. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Snaprx India was incorporated on 30 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Vijay Kumar Jadwani ceased to be Director on 09 Sep 2018. Dinesh Cheturam Kukreja was appointed as Director on 30 Jun 2016. Kamal Abhimanyu Kukreja was appointed as Director on 30 Jun 2016. Snaprx India has 4 board changes on record in total.
Snaprx India can be reached through the website snaprx.in. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Snaprx India is at 38 Pannalal Deshraj Layout Bank Colony Near Samadha Ashram Jaripatka, Nagpur, Maharashtra, India – 440014.
Snaprx India operates in the healthcare industry, in the healthtech and medical tech solutions segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
